DE602006015647D1 - Minimierung von hämodynamischem kompromiss bei pacing nach einem mi - Google Patents

Minimierung von hämodynamischem kompromiss bei pacing nach einem mi

Info

Publication number
DE602006015647D1
DE602006015647D1 DE602006015647T DE602006015647T DE602006015647D1 DE 602006015647 D1 DE602006015647 D1 DE 602006015647D1 DE 602006015647 T DE602006015647 T DE 602006015647T DE 602006015647 T DE602006015647 T DE 602006015647T DE 602006015647 D1 DE602006015647 D1 DE 602006015647D1
Authority
DE
Germany
Prior art keywords
pacing
hemodynamic compromise
minimizing
excitation pacing
minimizing hemodynamic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602006015647T
Other languages
German (de)
English (en)
Inventor
Joseph M Pastore
Rodney W Salo
Jesse W Hartley
Andrew P Kramer
Jeffrey E Stahmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiac Pacemakers Inc
Original Assignee
Cardiac Pacemakers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers Inc filed Critical Cardiac Pacemakers Inc
Publication of DE602006015647D1 publication Critical patent/DE602006015647D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A61N1/36843—Bi-ventricular stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A61N1/36842—Multi-site stimulation in the same chamber

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DE602006015647T 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi Expired - Lifetime DE602006015647D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67833705P 2005-05-06 2005-05-06
US11/276,741 US7742813B2 (en) 2005-05-06 2006-03-13 Minimizing hemodynamic compromise during post-mi remodeling control pacing
PCT/US2006/017388 WO2006121845A2 (en) 2005-05-06 2006-05-05 Minimizing hemodynamic compromise during post-mi pacing

Publications (1)

Publication Number Publication Date
DE602006015647D1 true DE602006015647D1 (de) 2010-09-02

Family

ID=37192407

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006015647T Expired - Lifetime DE602006015647D1 (de) 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi

Country Status (6)

Country Link
US (2) US7742813B2 (enExample)
EP (2) EP1901802B1 (enExample)
JP (1) JP4980345B2 (enExample)
AT (2) ATE474621T1 (enExample)
DE (1) DE602006015647D1 (enExample)
WO (1) WO2006121845A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7742813B2 (en) * 2005-05-06 2010-06-22 Cardiac Pacemakers, Inc. Minimizing hemodynamic compromise during post-mi remodeling control pacing
US7877140B2 (en) * 2005-09-06 2011-01-25 Cardiac Pacemakers, Inc. Pressure sensing for feedback control of post-MI remodeling control pacing
WO2010039501A1 (en) * 2008-10-03 2010-04-08 Cardiac Pacemakers, Inc. Methods and apparatuses for cardiac resynchronization therapy mode selection based on intrinsic conduction
EP2189111A1 (en) * 2008-11-21 2010-05-26 Pulsion Medical Systems AG Apparatus and method for determining a physiologic parameter
US8423141B2 (en) * 2009-01-30 2013-04-16 Medtronic, Inc. Pre-excitation stimulus timing based on mechanical event
US8886315B2 (en) * 2011-12-23 2014-11-11 Medtronic, Inc. Effectiveness of ventricular sense response in CRT

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190035A (en) 1981-06-18 1993-03-02 Cardiac Pacemakers, Inc. Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiological demand
US5626620A (en) 1995-02-21 1997-05-06 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US6076015A (en) 1998-02-27 2000-06-13 Cardiac Pacemakers, Inc. Rate adaptive cardiac rhythm management device using transthoracic impedance
US6640135B1 (en) * 2000-04-06 2003-10-28 Cardiac Pacemakers, Inc. Apparatus and method for spatially and temporally distributing cardiac electrical stimulation
US6823214B1 (en) 2000-09-08 2004-11-23 Cardiac Pacemakers, Inc. Self-calibrating rate-adaptive pacemaker
US7346394B2 (en) * 2001-04-27 2008-03-18 Cardiac Pacemakers, Inc. Cardiac stimulation at high ventricular wall stress areas
US6628988B2 (en) * 2001-04-27 2003-09-30 Cardiac Pacemakers, Inc. Apparatus and method for reversal of myocardial remodeling with electrical stimulation
US6748271B2 (en) * 2001-07-27 2004-06-08 Cardiac Pacemakers, Inc. Method and system for treatment of neurocardiogenic syncope
US6973349B2 (en) 2001-12-05 2005-12-06 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US6965797B2 (en) * 2002-09-13 2005-11-15 Cardiac Pacemakers, Inc. Method and apparatus for assessing and treating myocardial wall stress
US7065405B2 (en) * 2002-11-15 2006-06-20 Cardiac Pacemakers, Inc. Stress reduction pacing mode for arrhythmia prevention
US20040230219A1 (en) * 2003-05-12 2004-11-18 Roucher Leo R. Anchoring, supporting and centering catheter system for treating chronic total occlusions
US20050055058A1 (en) 2003-09-08 2005-03-10 Mower Morton M. Method and apparatus for intrachamber resynchronization
US7392084B2 (en) * 2003-09-23 2008-06-24 Cardiac Pacemakers, Inc. Demand-based cardiac function therapy
US7450988B2 (en) * 2004-06-04 2008-11-11 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US7366567B2 (en) * 2005-03-23 2008-04-29 Cardiac Pacemakers, Inc. Method for treating myocardial infarction
US7404802B2 (en) * 2005-05-05 2008-07-29 Cardiac Pacemakers, Inc. Trending of systolic murmur intensity for monitoring cardiac disease with implantable device
US7742813B2 (en) * 2005-05-06 2010-06-22 Cardiac Pacemakers, Inc. Minimizing hemodynamic compromise during post-mi remodeling control pacing

Also Published As

Publication number Publication date
WO2006121845A3 (en) 2007-01-18
US20100256702A1 (en) 2010-10-07
JP4980345B2 (ja) 2012-07-18
US7742813B2 (en) 2010-06-22
EP1901802A2 (en) 2008-03-26
EP2255844A1 (en) 2010-12-01
WO2006121845A2 (en) 2006-11-16
US8731666B2 (en) 2014-05-20
ATE552027T1 (de) 2012-04-15
EP2255844B1 (en) 2012-04-04
ATE474621T1 (de) 2010-08-15
JP2008539896A (ja) 2008-11-20
EP1901802B1 (en) 2010-07-21
US20060287683A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
DE60226267D1 (de) Gerät zur minimierung des ventrikulären remodelling nach infarkt
ATE510584T1 (de) Unterdrückung von hochfrequenz-pacing zur reduzierung von ischämischer erregbarkeit des myokards
EA200700058A1 (ru) Соединения, композиции и способы их использования
ATE494923T1 (de) Hämodynamisch kontrolliertes anti-tachyarrhythmie-schrittmachersystem
AU2003293068A1 (en) Determining relative depolarization at multiple cardiac sites
ATE551096T1 (de) Auswahl von pacing-stellen zur erhöhung der herzleistung
DE602007012496D1 (de) Verfahren zur Schmerzlinderung in Zusammenhang mit Nervenstimulation
DE60336731D1 (de) Vorrichtung zur detektion und behandlung von herzwand-belastung
DE50310859D1 (de) Setzwerkzeug mit mitteln zur kontrolle von setzvorg ngen
EP2498797A4 (en) TREATMENT OF HEART DISEASES
DE602005004022D1 (de) Intraokulare steroid-implantate mit verzögerter freisetzung über einen zeitraum von über 2 monaten
AU2003284010A1 (en) Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
DE60330266D1 (de) Verfahren zur beurteilung der wirksamkeit von chemotherapeutika
MX2025006207A (es) Composiciones que contienen arginasa i humana con un cofactor de metal de cobalto para usarse en el tratamiento de la deficiencia de arginasa 1
ATE474621T1 (de) Minimierung von hämodynamischem kompromiss bei pacing nach einem mi
ATE263805T1 (de) Verfahren zur verbesserung der verarbeitungscharakteristika von gefüllten polyolefinen
WO2020243627A3 (en) Anti-crispr inhibitors
BR0314252A (pt) Composição biocida, e, método de produção de uma composição biocida
ATE528041T1 (de) Gerät zur beendigung ventrikulärer tachykardie durch pacing
DE602005011428D1 (de) Batterieaufladeverfahren
WO2006076240A3 (en) Compositions, products and methods for controlling weight in a mammal
DE502006007113D1 (de) Aminosäuresalze von rosiglitazon
DE502005009430D1 (de) Verwendung von tensiden bei der metallgewinnung
DE602004005325D1 (de) Verwendung von polyanhydriden in antifouling-lacken sowie polyanhydride enthaltender antifouling-lack
ATE243529T1 (de) Kombination von ace-hemmern mit aldosteronantagonisten zur behandlung der ventrikulären hypertrophie